Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
The Breast Journal|November 18, 2003
Clinical experience with trastuzumab (herceptin)Charles L Vogel, Sandra X FrancoAnti-Cancer Drugs|April 8, 2003
Update on the current use of hormonals as therapy in advanced breast cancerCharles L VogelBreast Cancer Research and Treatment|September 30, 2011
Dual HER2-targeted approaches in HER2-positive breast cancerEugene R Ahn, Charles L VogelCancer Management and Research|January 19, 2019
Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancerReshma L Mahtani, Charles L VogelClinical Therapeutics|January 30, 2010
High-dose estrogen as salvage hormonal therapy for highly refractory metastatic breast cancer: a retrospective chart reviewReshma L Mahtani, Alisha Stein, Charles L VogelCancer Reports (Hoboken, N.J.)|May 14, 2026
Normalization of CEA, CA15-3, and CA27-29 Tumor Markers Following Single Lung Transplant in a Patient With a History of Early-Stage Breast Cancer and Idiopathic Pulmonary Fibrosis: A Case ReportYolcar Chamorro, Charles L Vogel, Ana C Sandoval-LeonClinical Breast Cancer|January 21, 2014
Toremifene for breast cancer: a review of 20 years of dataCharles L Vogel, Mary Ann Johnston, Christi Capers, et al.Cancer Investigation|November 22, 2002
Pegylated liposomal doxorubicin (Doxil) for metastatic breast cancer: the Cancer Research Network, Inc., experienceAlejandra T Perez, Gabriel H Domenech, Cynthia Frankel, et al.Clinical Breast Cancer|July 9, 2005
Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of lifeClifford A Hudis, Charles L Vogel, Julie R Gralow, et al.Breast Cancer Research and Treatment|November 27, 2004
Response to fulvestrant in heavily pretreated postmenopausal women: a single-center experienceSandra Franco, Alejandra Perez, Elizabeth Tan-Chiu, et al.Pageof 4